Back to mobile site

Amgen (AMGN) PT Raised to $265 at Oppenheimer

July 20, 2020 9:46 AM EDT Send to a Friend
Oppenheimer analyst Jay Olson raised the price target on Amgen (NASDAQ: AMGN) to $265.00 (from $252.00) while maintaining an Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login